Luz Alagon
Jul 29, 2016

Biotech Startup Challenges Validity of Bayer's Stivarga Patent

A biotech startup July 25 said it's challenging the validity of Bayer's patent covering its colorectal cancer medicine Stivarga ( Fustibal LLC v. Bayer, P.T.A.B., No. IPR2016-01490, petition filed 7/25/16 ).

http://www.bna.com/biotech-startup-challenges-n73014445546/